针对性降解sICOSL可以逆转细胞毒性T细胞功能障碍
Zhenghao Wu1,2,3, Peng Zheng4,5, Ruobing Qi6
1Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. wu_zhenghao@126.com.
Experimental hematology & oncology
|July 24, 2025
概括
增加可溶性ICOSL (sICOSL) 会损害细胞毒性T细胞 (CTL) 功能,恶化乳腺癌的存活率. 研究人员开发了纳米体-DPP4融合蛋白来降解sICOSL,提供了一种新的癌症免疫治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物化学 生物化学
背景情况:
- 细胞毒性T细胞 (CTL) 功能障碍是瘤免疫逃避的关键机制,导致癌症患者的生存率低下.
- 升的可溶性ICOSL (sICOSL) 水平与乳腺癌患者的生存率降低相关,表明其在疾病进展中的作用.
研究的目的:
- 调查sICOSL诱导CTL功能障碍的机制.
- 在癌症免疫治疗中确定针对sICOSL的治疗策略.
主要方法:
- 研究了sICOSL和CTL之间的相互作用,专注于ICOS受体内部化和降解.
- 鉴定出二乙酶-4 (DPP4) 是负责sICOSL分解的主要酶.
- 开发了纳米体-DPP4融合蛋白,用于针对性地降解sICOSL.
主要成果:
- sICOSL通过促进ICOS受体降解直接导致CTL功能障碍,这对于T细胞激活至关重要.
- 通过EZH2-介导的表观遗传变化,DPP4酶活性被化疗药物抑制.
- 新型纳米体-DPP4融合蛋白表明,sICOSL和瘤向能力的选择性降解.
结论:
- sICOSL是CTL功能障碍的关键调解者,也是乳腺癌的负预后因素.
- 针对性降解sICOSL代表了癌症免疫治疗的有希望的新途径.
- 开发的纳米体-DPP4融合蛋白为增强抗瘤免疫提供了潜在的治疗工具.
更多相关视频
08:49Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
9.2K
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.3K
相关概念视频
Cytotoxic T Cells-mediated Immune Response
2.1K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.1K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Tumor Immunotherapy
662
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
662
